Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Immunology and Microbiology
T Cell
100%
Hematopoietic Cell
97%
Humanized Mouse
88%
Mouse Model
73%
Factor VIII
67%
Graft-Versus-Host Disease
62%
Thymus
56%
Immune System
52%
In Vitro
50%
Antigen
43%
B Cell
43%
CD34
40%
Endothelial Cells
39%
Lentivirus Vector
38%
Engraftment
37%
Dendritic Cell
33%
Autoimmunity
33%
Cancer Cell
33%
Autoimmune Disease
31%
Immune Response
30%
Cell Line
29%
T Cell Receptor
27%
Transgenics
27%
Gene Transfer
25%
Ribonucleic Acid
25%
Cytotoxic T-Cell
22%
Transgene
22%
Immune Tolerance
22%
Homeostasis
21%
Unfolded Protein Response
19%
Tumor Necrosis Factor
19%
Immunotherapy
19%
Antibody Generation
19%
Monocyte
19%
Macrophage
18%
Human Cell
18%
Hematopoiesis
17%
Allograft
17%
Steady State
16%
Host Cell
16%
Fas Ligand
16%
Interleukin 6
16%
Natural Killer T Cell
16%
Tumor-Associated Macrophage
16%
Systemic Scleroderma
16%
Induced Pluripotent Stem Cell
16%
CD31
16%
Flt3 Ligand
16%
CD135 Antigen
16%
Experimental Model
16%
Keyphrases
Hemophilia
95%
Graft-versus-host Disease (GvHD)
55%
Factor VIII (FVIII)
53%
Bone Marrow
39%
Lentiviral Vector
38%
Gene Therapy
37%
Humanized Mice
33%
Tumor Activity
33%
Graft-versus-tumor
33%
Adult Human Bone Marrow
32%
Bone Marrow Cells
26%
Human Adult
25%
Flow Cytometry
24%
Immune Tolerance
22%
T Cells
22%
Haemophilia A Mice
21%
Coagulation
21%
Cell-derived
20%
Engraftment
19%
Endothelial Cells
19%
Donor T Cell
19%
Humanized Mouse Model
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Hematopoietic Cells
16%
Dendritic Cells
16%
CD8+ T Cells
16%
Human Mesenchymal Stem Cells (hMSCs)
16%
Malaria
16%
Host Cell
16%
Tissue-restricted Antigens
16%
Preclinical Animal Models
16%
Blood Cells
16%
Skeletal muscle Differentiation
16%
Vector Interaction
16%
Liver Cell Transplantation
16%
Disease Challenge
16%
Fetal Liver Cells
16%
Therapeutic Efficacy
16%
Human Infectious Diseases
16%
Hepatitis Virus
16%
Fas Ligand
16%
Patient-specific iPSCs
16%
Renal Cell Carcinoma
16%
Differentiation Potential
16%
Malignant Plasma Cells
16%
Autoimmune Process
16%
Vessel Stabilization
16%
Autoreactive T Cells
16%
Cell Variations
16%
Intracellular Detection
16%
